Racheal Lee
May 9, 2013

Takeda names Fortune Indonesia to promote Vitamin C product

JAKARTA - Japanese pharmaceutical company Takeda has handed the creative business of Vitacimin to independent full-service agency Fortune Indonesia.

Takeda names Fortune Indonesia to promote Vitamin C product

The appointment came after a pitch called in March, which involved agencies including Dentsu and Matari Advertising. The two-year contract will see Fortune Indonesia driving an integrated marketing communications campaign, which includes above the line, below the line and digital.

Vitacimin is a Vitamic C product in Indonesia, and the company is hoping to reach out to teens as a new target segment while maintaining its current dominance within the youth and adult target segments.

The brand plan is to engage teenagers by adopting a health and beauty approach with the key message revolvig around being active, confident and energetic all day long.

The plan is to use an Indonesian female teen group as the brand ambassador to represent the personality of the brand and to deliver the message to the audience.

Maintaining category leadership while widening the market is a challenging objective, said Sapto Handriyanto, innovation and business development director at Fortune Indonesia. "Therefore we studied the success campaign history of Vitacimin and we found out that the jingle is one of the strongest identities of the brand," Handriyanto said. "Using a jingle as the main vehicle, we convinced the client to make the benefits of Vitamin C more relevant toward modern life and wrap it together in a catchy jingle.”

Source:
Campaign Asia

Related Articles

Just Published

1 day ago

Publicis climbs the highest in APAC media rankings ...

PHD retains the overall lead, as Omnicom Media Group sees an end-of-year boost from Tata Motors' win, and Publicis Media rockets to the sixth spot.

2 days ago

Netflix is going all out for Squid Game season ...

With a Golden Globe nomination secured even before its release, the record-breaking series returns on December 26, backed by Netflix’s boldest marketing push yet.